PATIENCE JOHN — SEC insider filings

SEC reporting owner CIK 1021413. 37 insider filings on record with FilingPulse; latest filed 2026-10-02.

Transaction summary — filings shown

Covers all 37 filings on record, filed 2020-11-03 to 2026-10-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
BIODESIX INC (BDSX)Director2710 legs · 2,313,875 sh · $4,044,584—54
Accelerate Diagnostics, Inc (AXDX)Director102 legs · 216,666 sh · $314,000—9

Insider filings — PATIENCE JOHN

FiledFormIssuerReported transactionsSource
2026-10-024BIODESIX INC (BDSX)Option exercise (M): 1,360 · Option exercise (M): 1,360 (derivative) @ $0EDGAR
2026-07-024BIODESIX INC (BDSX)Option exercise (M): 1,361 · Option exercise (M): 1,361 (derivative) @ $0EDGAR
2026-04-024BIODESIX INC (BDSX)Option exercise (M): 1,361 · Option exercise (M): 1,361 (derivative) @ $0EDGAR
2026-01-064BIODESIX INC (BDSX)Option exercise (M): 1,143 · Grant/award (A): 5,443 (derivative) @ $0 · Grant/award (A): 6,354 (derivative) @ $0 · Option exercise (M): 1,143 (derivative) @ $0EDGAR
2025-10-024BIODESIX INC (BDSX)Option exercise (M): 1,144 · Option exercise (M): 1,144 (derivative) @ $0EDGAR
2025-07-024BIODESIX INC (BDSX)Option exercise (M): 22,874 · Option exercise (M): 22,874 (derivative) @ $0EDGAR
2025-05-224BIODESIX INC (BDSX)Grant/award (A): 68,621 (derivative) @ $0 · Grant/award (A): 42,010 (derivative) @ $0EDGAR
2025-04-024BIODESIX INC (BDSX)Option exercise (M): 46,686 · Option exercise (M): 46,686 (derivative) @ $0EDGAR
2024-12-034Accelerate Diagnostics, Inc (AXDX)Purchase (P): 200,000 @ $1.57EDGAR
2024-11-064BIODESIX INC (BDSX)Purchase (P): 75,000 @ $1.38EDGAR
2024-05-234BIODESIX INC (BDSX)Option exercise (M): 217,400 · Grant/award (A): 46,686 (derivative) @ $0 · Grant/award (A): 37,050 (derivative) @ $0 · Option exercise (M): 5,435 (derivative) @ $0EDGAR
2024-05-214Accelerate Diagnostics, Inc (AXDX)Grant/award (A): 66,667 (derivative) @ $0EDGAR
2024-04-094BIODESIX INC (BDSX)Grant/award (A): 5,435 (derivative) @ $46EDGAR
2024-01-254Accelerate Diagnostics, Inc (AXDX)Purchase (P): 16,666 · Purchase (P): 16,666 (derivative)EDGAR
2024-01-034BIODESIX INC (BDSX)Grant/award (A): 105,389 (derivative) @ $0EDGAR
2023-08-074BIODESIX INC (BDSX)Grant/award (A): 61,728 @ $1.62EDGAR
2023-06-294Accelerate Diagnostics, Inc (AXDX)Grant/award (A): 236,842 (derivative) @ $0EDGAR
2023-06-014Accelerate Diagnostics, Inc (AXDX)Grant/award (A): 78,947 (derivative) @ $0EDGAR
2023-05-254BIODESIX INC (BDSX)Grant/award (A): 28,873 (derivative) @ $0EDGAR
2023-01-054BIODESIX INC (BDSX)Grant/award (A): 4,878 (derivative) @ $0EDGAR
2023-01-044BIODESIX INC (BDSX)Grant/award (A): 62,500 (derivative) @ $0EDGAR
2022-11-214BIODESIX INC (BDSX)Purchase (P): 1,739,130 @ $1.15EDGAR
2022-06-024Accelerate Diagnostics, Inc (AXDX)Grant/award (A): 75,949 (derivative) @ $0EDGAR
2022-05-264BIODESIX INC (BDSX)Grant/award (A): 83,333 (derivative) @ $0EDGAR
2022-04-114BIODESIX INC (BDSX)Purchase (P): 279,329 @ $1.79EDGAR
2022-01-044BIODESIX INC (BDSX)Purchase (P): 137,931 @ $4.35 · Purchase (P): 22,988 @ $4.35EDGAR
2021-12-104Accelerate Diagnostics, Inc (AXDX)Grant/award (A): 21,702 @ $7.68EDGAR
2021-11-244BIODESIX INC (BDSX)Purchase (P): 10,000 @ $6.18EDGAR
2021-11-224BIODESIX INC (BDSX)Purchase (P): 9,497 @ $6.34EDGAR
2021-08-234BIODESIX INC (BDSX)Purchase (P): 8,396 @ $8.04EDGAR
2021-08-194BIODESIX INC (BDSX)Purchase (P): 1,604 @ $7.12EDGAR
2021-07-014BIODESIX INC (BDSX)Grant/award (A): 34,385 (derivative) @ $0EDGAR
2021-05-244Accelerate Diagnostics, Inc (AXDX)Grant/award (A): 35,168 (derivative) @ $0EDGAR
2021-04-134Accelerate Diagnostics, Inc (AXDX)Grant/award (A): 21,701 @ $7.68EDGAR
2021-02-234Accelerate Diagnostics, Inc (AXDX)Grant/award (A): 21,701 @ $7.68EDGAR
2020-12-094BIODESIX INC (BDSX)Option exercise (M): 35,157 @ $6.83 · Option exercise (M): 23,440 @ $6.83 · Option exercise (M): 35,157 (derivative) @ $0 · Option exercise (M): 23,440 (derivative) @ $0EDGAR
2020-11-034BIODESIX INC (BDSX)Conversion (C): 1,829,368 · Conversion (C): 2,501,974 · Conversion (C): 245,041 · Conversion (C): 81,600 @ $14.40 · Conversion (C): 64,416 @ $14.40 · Purchase (P): 30,000 @ $18 · +15 moreEDGAR

FilingPulse's Form 4 archive currently extends back to 2020-10-29 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1021413 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs